Hemoglobinopathies in North Africa: A Review

REFERENCES

• Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 3rd ed. Oxford: Blackwell Scientific; 1981.
   Google Scholar
• Hardison RC, Chui DHK, Giardine B, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225–223 (http://globin.cse.psu.edu).
   Google Scholar
• Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537-D541 (http://globin.cse.psu.edu).
   Google Scholar
• Kaplan JC, Delpech M. Génétique moléculaire de quelques maladies constitutionnelles. Biologie Moléculaire et Médecine. Paris: Flammarion, Médecine-Sciences. 1989:273–338.
   Google Scholar
• Pissard S, M'Rad A, Beuzard Y, Roméo PH. A new type of hereditary persistence of fetal haemoglobin (HPFH): HPFH Tunisia β+ (+C−200) Gγ. Br J Haematol 1996;95(1):67–72.
   PubMed Web of Science ®Google Scholar
• Flint J, Hill AVS, Bowden DK, Oppenheimer SJ. High frequencies of thalassemia are the result of natural selection by malaria. Nature 1986;321(6072):744–750.
   PubMed Web of Science ®Google Scholar
• Galactéros F. Drépanocytose. Physiopathologie et diagnostic. Rev Prat 1995;45(3):351–361.
   PubMedGoogle Scholar
• Fattoum S. Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data. Tunis Med 2006;84(11):687–696.
   PubMedGoogle Scholar
• Fawzi ZO, Al Hilali A, Fakhroo N, Al Bin Ali A, Al Mansour S. Distribution of Hemoglobinopathies and Thalassemias in Qatari Nationals Seen at Hamad Hospital in Qatar. Qatar Med J 2003;12(1):20–24.
   Google Scholar
• Benkirane Agoumi N, Sebar A. Les hémoglobinopathies au Maroc. Arch Pédiatr 2003;10(7):648–657.
   PubMed Web of Science ®Google Scholar
• Rosa J, Wajcman H, Blouquit Y. Hémoglobine. Encycl Méd Chir, Hématologie. France: Editions Techniques. 1993; 14 (13000-S-10).
   Google Scholar
• Babiker MM, Bachir N, Sarsour N. Prevalence of thalassaemia in schoolchildren in north-eastern Badia, Jordan. East Mediterr Health J 1999;5(6):1165–1170.
   PubMedGoogle Scholar
• Agouti I, Badens C, Abouyoub A, Genotypic correlation between six common β-thalassemia mutations and the XmnI polymorphism in the Moroccan population. Hemoglobin 2007;31(2):141–149.
   PubMed Web of Science ®Google Scholar
• Fuchaoren S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin 1987;11(1):65–88.
   PubMed Web of Science ®Google Scholar
• Siala H, Ouali F, Messaoud T, Bibi A, Fattoum S. α-Thalassaemia in Tunisia: some epidemiological and molecular data. J Genet 2008;87(3):229–234.
   PubMed Web of Science ®Google Scholar
• Williams TN, Mailand K, Ganczakowski M, Red blood cell phenotypes in α+ thalassaemias from early childhood to maturity. Br J Haematol 1996;95(2):266–272.
   PubMed Web of Science ®Google Scholar
• Favier R, Ozsahin H, Laire V, Douay L. Apport du laboratoire dans le dépistage et le diagnostic des hémoglobinopathies en milieu pédiatrique. Rev Fr Lab 1993;248:53–62.
   Google Scholar
• Wilson JB, Headlee ME, Huisman THJ. A new high-performance liquid chromatography procedure for the separation and quantitation of various hemoglobin variants in adults and new born babies. J Lab Clin Med 1983;102(2):174–186.
   PubMed Web of Science ®Google Scholar
• Siguret V, Andreux J-P. Diagnostic biologique des hémoglobinopathies par analyse du phénotype. Ann Biol Clin 1997;55(2):103–112.
   PubMedGoogle Scholar
• Maier-Redelsperger M, Girot R. Diagnostic des maladies de l'hémoglobine. Les Feuilles de Biologie 1989;30:29–38.
   Google Scholar
• Chibani J, Gritli E, Khelif A, Ben Ahmed S. Hémoglobinopathies en Tunisie centarle: les premiers pas du conseil génétique. Nouv Rev Fr Hématol 1986;28(4):231–233.
   PubMedGoogle Scholar
• Frikha M, Fakhfakh F, Mseddi S, Hemoglobin βS haplotype in the Kebili region (southern Tunisia). Transfus Clin Biol 1998;5(2):166–172.
   PubMed Web of Science ®Google Scholar
• Sassi R, Hmida S, Kaabi H, Prevalence of C282Y and H63D mutations in the haemochromatosis (HFE) gene in Tunisian population. Ann Genet 2004;47(4):325–330.
   PubMedGoogle Scholar
• Leclerc T, Guetarni D, Bernet A, Colonna P, Godet J, Morlé F. Identification of three different α-thalassemic haplotypes: −α3.7, − −MED and αHphα in the same Algerian family. Hum Mutat 1995;5(2):182–183.
   PubMed Web of Science ®Google Scholar
• Bennani C, Tamouza R, Rouabhi F, The spectrum of β-thalassaemia in Algeria: possible origins of the molecular heterogeneity and a tentative diagnostic strategy. Br J Haematol 1993;84(2):335–337.
   PubMed Web of Science ®Google Scholar
• Rouabhi F, Lapoumeroulie C, Amselem S, DNA haplotype distribution in Algerian β thalassemia patients: an extended evaluation by family studies and representative molecular characterization. Hum Genet 1988;79(4):373–376.
   PubMed Web of Science ®Google Scholar
• Fattoum S, Guemira F, Oner C, Li HW, Kutlar F, Huisman THJ. β-Thalassemia, Hb S-β-thalassemia and sickle cell anemia among Tunisians. Hemoglobin 1991;15(1):11–21.
   PubMed Web of Science ®Google Scholar
• Chebil-Laradi S, Pousse H, Khelif A, Screening of hemoglobinopathies and molecular analysis of β-thalassemia in Central Tunisia. Arch Pediatr 1994;1(12):1100–1105.
   PubMed Web of Science ®Google Scholar
• Chouk I, Daoud BB, Mellouli F, Contribution to the description of the β-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin 2004;28(3):189–195.
   PubMed Web of Science ®Google Scholar
• Abdennebi M, Messaoud T, Zouari F, Fattoum S. Prenatal diagnosis of sickle cell anemia. Tunis Med 1994;72(11):601–606.
   PubMedGoogle Scholar
• Zorai A, Abbes S, Préhu C, Hb H disease among Tunisians: molecular characterization of α-thalassemia determinants and hematological findings. Hemoglobin 2003;27(1):57–61.
   PubMed Web of Science ®Google Scholar
• Haj Khelil A, Laradi S, Miled A, Omar Tadmouri G, Ben Chibani J, Perrin P. Clinical and molecular aspects of haemoglobinopathies in Tunisia. Clin Chim Acta 2004;340(1–2):127–137.
   PubMed Web of Science ®Google Scholar
• Fattoum S, Messaoud T, Bibi A. Molecular basis of β-thalassemia in the population of Tunisia. Hemoglobin 2004;28(3):177–187.
   PubMed Web of Science ®Google Scholar
• Siala H, Fattoum S, Messaoud T, Ouali F, Gerard N, Krishnamoorthy R. A novel α-thalassemia nonsense mutation in codon 23 of the α2-globin gene (GAG→TAG) in a Tunisian family. Hemoglobin 2004;28(3):249–254.
   PubMed Web of Science ®Google Scholar
• Bibi A, Messaoud T, Fattoum S. Haplotypes linked to three rare β-thalassemia mutations, originally reported in Tunisia. Hemoglobin 2006;30(2):175–181.
   PubMed Web of Science ®Google Scholar
• Mellouli F, El Borgi W, Kaabi H, HFE gene mutations in Tunisian major β-thalassemia and iron overload. Transfus Clin Biol 2006;13(6):353–357.
   PubMed Web of Science ®Google Scholar
• Regaya F, Oussaief L, Bejaoui M, Karoui M, Zili M, Khelifa R. Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia. BMC Infect Dis 2007;25(7):123–129.
   Google Scholar
• Bouhass R, Aguercif M, Trabuchet G, Godet J. A new mutation at IVS1 nt 2(T→A), in β-thalassemia from Algeria. Blood 1990;76(5):1054–1055.
   PubMed Web of Science ®Google Scholar
• Bienvenu T, Sebillon P, Labie D, Kaplan JC, Beldjord C. Rapid and direct detection of the most frequent Mediterranean β-thalassemic mutations by multiplex allele-specific enzymatic amplification. Hum Biol 1992;64(1):107–113.
   PubMed Web of Science ®Google Scholar
• Périchon B, Ragusa A, Lapouméroulie C, Inter-ethnic polymorphism of the β-globin gene locus control region (LCR) in sickle-cell anemia patients. Hum Genet 1993;91(5):464–468.
   PubMed Web of Science ®Google Scholar
• Perrin P, Bouhassa R, Mselli L, Diversity of SNP haplotypes associated with β-thalassemia mutations in Algeria: implications for their origin. Gene 1998;213(1–2):169–177.
   PubMed Web of Science ®Google Scholar
• Agouti I, Badens C, Abouyoub A, Levy N, Bennani M. Molecular basis of β-thalassemia in Morocco: possible origins of the molecular heterogeneity. Genet Test 2008;12(4):563–568.
   PubMedGoogle Scholar
• Guemira F, Abbes S, Ducrocq R, Elion J, Fattoum S. Hb D Iran-β-thalassemia association in a Tunisian family. Ann Pediatr (Paris) 1992;39(6):369–374.
   PubMedGoogle Scholar
• Laradi S, Haj Khelil A, Omri H, Analyse moléculaire et diagnostic prénatal de la β-thalassemie: à propos de notre expérience en Tunisie centrale. Ann Biol Clin 2000;58(4):459–460.
   Google Scholar
• Moumni I, Zorai A, Daoued BB, Hb A2-Pasteur-Tunis [δ59(E3)Lys→Asn, AAG→AAC]: a new δ chain variant detected by DNA sequencing in a Tunisian carrier of the codon 39 (C→T) β0-thalassemia mutation. Hemoglobin 2007;31(1):23–29.
   PubMed Web of Science ®Google Scholar
• Bennani C, Bouhass R, Perrin-Pécontal P, Anthropological approach to the heterogeneity of β-thalassemia mutations in northern Africa. Hum Biol 1994;66(3):369–382.
   PubMed Web of Science ®Google Scholar
• Boudrahem-Addour N, Zidani N, Carion N, Labie D, Belhani M, Beldjord C. Molecular heterogeneity of β-thalassemia in Algeria: how to face up to a major health problem. Hemoglobin 2009;33(1):24–36.
   PubMed Web of Science ®Google Scholar
• Lemsaddek W, Picanço I, Seuanes F, The β-thalassemia mutation/haplotype distribution in the Moroccan population. Hemoglobin 2004;28(1):25–37.
   PubMed Web of Science ®Google Scholar
• Jacquette A, Le Roux G, Lacombe C, Goossens M, Pissard S. Compound heterozygosity for two new mutations in the β-globin gene [codon 9 (+TA) and polyadenylation site (AATAAA→AAAAAA)] leads to thalassemia intermedia in a Tunisian patient. Hemoglobin 2004;28(3):243–248.
   PubMed Web of Science ®Google Scholar
• Wajcman H, Belkhodja O, Labie D. Hb Setif: G1 (94) Asp→Tyr. A new chain hemoglobin variant with substitution of the residue involved in hydrogen bond between unlike subunits. FEBS Lett 1972;27(2):298–300.
   PubMed Web of Science ®Google Scholar
• Chami B, Blouquit Y, Bardakdjian-Michau J, Hemoglobin variants in North Africa. Hemoglobin 1994;18(1):39–51.
   PubMed Web of Science ®Google Scholar
• Lefranc MP, Lefranc G, Farhat M, Frequency of human Aγ75 Thr globin chain in a population from Tunisia. Hum Genet 1981;59(1):89–91.
   PubMed Web of Science ®Google Scholar
• Blouquit Y, Lacombe C, Arous N, Seven new cases of Hemoglobin Camperdown α2β2104(G6)Arg→Ser found in Malta, Sicily and Tunisia. Hemoglobin 1984;8(6):613–619.
   PubMed Web of Science ®Google Scholar
• Delanoe-Garin J, Arous N, Blouquit Y, Hemoglobin Kenitra α2β269(E13)Gly→Arg. A new β variant of elevated expression associated with α-thalassemia, found in a Moroccan woman. Hemoglobin 1985;9(1):1–9.
   PubMed Web of Science ®Google Scholar
• Dahmane-Arbane M, Blouquit Y, Arous N, Hemoglobin Boumerdès α237(C2) Pro→Argβ2: a new variant of the α chain associated with Hemoglobin S in an Algerian family. Nouv Rev Fr Hematol 1987;29(5):317–320.
   PubMedGoogle Scholar
• Baklouti F, Baudin-Chich V, Kister J, Increased oxygen affinity with normal heterotropic effects in Hemoglobin Loire [α88(F9)Ala→Ser]. Eur J Biochem 1988;177(2):307–312.
   PubMedGoogle Scholar
• Baklouti F, Francina A, Dorléac E, Asymptomatic association of Hemoglobin Dunn (α6[A4]Asp→Asn) and Hemoglobin O-Arab (β121[GH4]Glu→Lys) in a Moroccan man. Am J Hematol 1988;27(4):253–256.
   PubMed Web of Science ®Google Scholar
• Mrad A, Arous N, Kastally R, Blibech R, Rosa J, Galacteros F. First observation of Hb Montgomery [α48(CD6)Leu→Arg] in Tunisia. Hemoglobin 1988;12(1):67–70.
   PubMed Web of Science ®Google Scholar
• Mrad A, Blouquit Y, Lacombe C, Hb Tunis [α2β2124(H2)Pro→Ser], a new β chain variant identified by HPLC. Hemoglobin 1988;12(1):23–30.
   PubMed Web of Science ®Google Scholar
• Mrad A, Kister J, Feo C, Hemoglobin Athens-Georgia [α2β240(C6)Arg→Lys] in association with β0-thalassemia in Tunisia. Am J Hematol 1989;2(2):117–122.
   Google Scholar
• Molchanova TP, Wilson JB, Gu LH, Guemira F, Fattoum S, Huisman THJ. Hb Bab-Saadoun or α2β248(CD7)Leu→Pro, a mildly unstable variant found in an Arabian boy from Tunisia. Hemoglobin 1992;16(4):267–273.
   PubMed Web of Science ®Google Scholar
• Guemira F, Abbes S, Ducrocq R, Elion J, Fattoum S. Hb D Iran-β-thalassemia association in a Tunisian family. Ann Pediatr (Paris) 1992;39(6):369–374.
   PubMedGoogle Scholar
• Elion J, Belkhodja O, Wajcman H, Labie D. Two variants of Hemoglobin D in the Algerian population: Hemoglobin D Ouled Rabah 19(BI)Asn→Lys and Hemoglobin D Iran 22(Br)Glu→Gln. Biochim Biophys Acta 1973;310(2):360–364.
   PubMedGoogle Scholar
• Wajcman H, Kalmès G, Groff P, Promé D, Riou J, Galacteros F. Hb Melusine [α114(GH2)Pro→Ser]: a new neutral hemoglobin variant. Hemoglobin 1993;17(5):397–405.
   PubMed Web of Science ®Google Scholar
• Darbellay R, Mach-Pascual S, Rose K, Graf J, Ph Beris. Haemoglobin Tunis-Bizerte: a new α1 globin 129 Leu→Pro unstable variant with thalassaemic phenotype. Br J Haematol 1995;90(1):71–76.
   PubMed Web of Science ®Google Scholar
• Wajcman H, Borensztajn K, Riou J, Two new Gγ chain variants: Hb F-Clamart [γ17(A14)Lys→Asn] and Hb F-Ouled Rabah [γ19(B1)Asn→Lys]. Hemoglobin 2000;24(1):45–52.
   PubMed Web of Science ®Google Scholar
• Wajcman H, Drupt F, Henthorn JS, Two new variants with the same substitution at position β122: Hb Bushey [β122(GH5)Phe→Leu] and Hb Casablanca [β65(E9)lys→Met;β122(GH5)Phe→Leu]. Hemoglobin 2000;24(2):125–132.
   PubMed Web of Science ®Google Scholar
• Siala H, Ouali F, Messaoud T, Sfar R, Fattoum S. First description in Tunisia of a point mutation at codon 119 (CCT→TCT) in the α1-globin gene: Hb Groene Hart associated with −α3.7. Hemoglobin 2005;29(4):263–268.
   PubMed Web of Science ®Google Scholar
• Zorai A, Harteveld CL, Bakir A, van Delft P, Falfoul A, Dellagi K. Molecular spectrum of α-thalassemia in Tunisia: epidemiology and detection at birth. Hemoglobin 2002;26(4):353–362.
   PubMed Web of Science ®Google Scholar
• Mesbah-Amroun H, Rouabhi F, Ducrocq R, Elion J. Molecular basis of α-thalassemia in Algeria. Hemoglobin 2008;32(3):273–278.
   PubMed Web of Science ®Google Scholar
• Giordano PC, Zweegman S, Akkermans N, The first case of Hb Groene Hart [α119(H2) Pro→Ser, CCT→TCT (α1)] homozygosity confirms that a thalassemia phenotype is associated with this abnormal hemoglobin variant. Hemoglobin 2007;31(2):179–182.
   PubMed Web of Science ®Google Scholar
• Beldjord C, Lapouméroulie C, Baird ML, D. Four new haplotypes observed in Algerian β-thalassemia patients. Hum Genet 1983;65(2):204–206.
   PubMed Web of Science ®Google Scholar
• Eskandarani HA. Ethical concerns to the use of pre-implantation genetic diagnosis in the Gulf Cooperative Council States. Second Pan Arab Human Genetics Conference, Dubai, United Arab Emirates, 20–22 November 2007 (http//cags.org.ae/2ndpahgcabstracts.html).
   Google Scholar
• Kan YW, Dozy AM. Polymorphism of DNA sequence adjacent to human β-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci USA 1978;5(11):5631–5635.
   Google Scholar
• Orkin SH, Little PF, Kazazian HHJr, Boehm CD. Improved detection of the sickle mutation by DNA analysis: application to prenatal diagnosis. N Engl J Med 1982;307(1):32–36.
   PubMed Web of Science ®Google Scholar
• Chibani J, Vidaud M, Duquesnoy P, The peculiar spectrum of β-thalassemia genes in Tunisia. Hum Genet 1988;78(2):190–192.
   PubMed Web of Science ®Google Scholar
• Pagnier J, Mears JG, Dunda-Belkhodja O, Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci USA 1984;81(6):1771–1773.
   PubMed Web of Science ®Google Scholar
• Bloom M, Ed. Understanding Sickle Cell Disease. Understanding Health and Sickness Series. Jackon: University Press of Mississippi. 1995:33–34.
   Google Scholar
• Henni T, Morlé F, Lopez B, Colonna P, Godet J. α-Thalassemia haplotypes in the Algerian population. Hum Genet 1987;75(3):272–276.
   PubMed Web of Science ®Google Scholar
• Lemsaddek W, Picanço I, Seuanes F, Spectrum of β thalassemia mutations and Hb F levels in the heterozygous Moroccan population. Am J Hematol 2003;73(3):161–168.
   PubMed Web of Science ®Google Scholar
• Trabuchet G, Elion J, Baudot G, Origin and spread of β-globin gene mutations in India, Africa and Mediterranea: analysis of the 5′-flanking and intragenic sequences of βS and βC genes. Hum Biol 1991;63(3):241–252.
   PubMed Web of Science ®Google Scholar
• Abbes S, Fattoum S, Vidaud M, Goossens M, Rosa J. Sickle cell anemia in the Tunisian population: haplotyping and Hb F expression. Hemoglobin 1991;15(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Flint J, Harding RM, Clegg JB, Boyce AJ. Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants. Hum Genet 1993;91(2):91–117.
   PubMed Web of Science ®Google Scholar
• Tadmouri GO, Garguier N, Demont J, Perrin P, Basak AN. History and origin of β-thalassemia in Turkey: SNP haplotype diversity of the β globin genes. Hum Biol 2001;73(5):661–674.
   PubMed Web of Science ®Google Scholar
• Inati A, Taher A, Bou Alawi W, β-Globin gene cluster haplotypes and Hb F levels are not the only modulators of sickle cell disease in Lebanon. Eur J Haematol 2003;70(2):79–83.
   PubMed Web of Science ®Google Scholar
• Zahed L, Demont J, Bouhass R, Origin and history of the IVS-I-110 and codon 39 β-thalassemia mutations in the Lebanese population. Hum Biol 2002;74(6):837–847.
   PubMed Web of Science ®Google Scholar
• Labie D, Dunda-Belkhodja O, Rouabhi F, Pagnier J, Ragusa A, Nagel RL. The −158 site 5′ to the Gγ gene and Gγ expression. Blood 1985;66(6):1463–1465.
   PubMed Web of Science ®Google Scholar
• Currat M, Trabuchet G, Rees D, Molecular analysis of the β-globin gene cluster in the Niokholo Mandenka population reveals a recent orgin of the βS Senegal mutation. Am J Hum Genet 2002;70(1):207–223.
   PubMed Web of Science ®Google Scholar
• Henderson S, Timbs A, McCarthy J, Incidence of hemoglobinopathies in various populations − the impact of immigration. Clin Biochem 2009;42(18):1745–1756.
   PubMed Web of Science ®Google Scholar
• Orkin SH, Goff SC, Nathan DG. Heterogeneity of DNA deletion in αδβ-thalassemia. J Clin Invest 1981;67(3):878–884.
   PubMed Web of Science ®Google Scholar
• Tadmouri GO, Tüzman S, Ozçelik H, Molecular and population genetic analyses of β-thalassemia in Turkey. Am J Hematol 1998;57(3):215–220.
   PubMed Web of Science ®Google Scholar
• Baklouti F, Dorléac E, Morlé L, Homozygous Hemoglobin Knossos (α2β227(B9)Ala→Ser): a new variety of β+-thalassemia intermedia associated with δ0-thalassemia. Blood 1986;67(4):957–961.
   PubMed Web of Science ®Google Scholar
• Tadmouri GO, Bilenoğlu O, Kantarci S, Kayserili H, Perrin P, Başak AN. A rare mutation [IVS-I-130 (G→A)] in a Turkish β-thalassemia major patient. Am J Hematol 2000;63(4):223–225.
   PubMed Web of Science ®Google Scholar
• Deidda G, Novelletto A, Hafez M, A new β-thalassemia mutation produced by a single nucleotide substitution in the conserved dinucleotide sequence of the IVS-I consensus acceptor site (AG→AA). Hemoglobin 1990;14(4):431–440.
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, van Delft P, Giordano PC. Molecular spectrum of α-thalassemia in the Iranian population of Hormozgan: three novel point mutation defects. Am J Hematol 2003;74(2):99–103.
   PubMed Web of Science ®Google Scholar
• Hellani A, Fadel E, El-Sadadi S, El-Sweilam H, El-Dawood A, Abu-Amero KK. Molecular spectrum of α-thalassemia mutations in microcytic hypochromic anemia patients from Saudi Arabia. Genet Test Mol Biomarkers 2009;13(2):219–221.
   PubMed Web of Science ®Google Scholar
• Fichera M, Spalletta A, Fiorenza F, Molecular basis of α-thalassemia in Sicily. Hum Genet 1997;99(3):381–386.
   PubMed Web of Science ®Google Scholar
• Bernini LF. Geographic distribution of α-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge: Cambridge University Press. 2001;878–894.
   Google Scholar
• Gilman JG, Huisman THJ. DNA sequence variation associated with elevated fetal Gγ globin production. Blood 1985;66(4):783–787.
   PubMed Web of Science ®Google Scholar
• Karimi M, Yarmohammadi H, Farjadian S, β-Thalassemia intermedia from southern Iran: IVS-II-1 (G→A) is the prevalent thalassemia intermedia allele. Hemoglobin 2002;26(2):147–154.
   PubMed Web of Science ®Google Scholar
• Birben E, Oner C, Oner R, Severe β-thalassemia in frameshift codon 6 (−A) homozygotes: effects of haplotype on phenotype. Hemoglobin 2001;25(4):441–445.
   PubMed Web of Science ®Google Scholar
• Hemat C, Nibourel O, Maboudou P, Thalassémie β0/β0 avec phénotype “intermédiaire”: un diagnostic rare auquel il faut penser. Ann Biol Clin 2006;64(4):341–345.
   PubMedGoogle Scholar
• Fullerton SM, Bond J, Schneider JA, Polymorphism and divergence in the β-globin replication origin initiation region. Mol Biol Evol 2000;17(1):179–188.
   PubMed Web of Science ®Google Scholar
• Haj Khelil A, Deguillien M, Morinière M, Ben Chibani J, Baklouti F. Cryptic splicing sites are differentially utilized in vivo. FEBS J 2008;275(6):1150–1162.
   PubMed Web of Science ®Google Scholar